Furthermore, during actual adenoviral injection in the tumor, infected tumor cells could also present TAAs to other types of immune cells, such as CD4+ T helper cells, to regulate the immunity toward an adaptive anti-tumor one. This evidence concerns the gene CD4 and neoplasm.